Euromedic International Holdings B.V, a pan-European healthcare services provider headquartered in Budapest, has announced that Ares Life Sciences (ALS) and Merrill Lynch Global Private Equity (MLGPE) will acquire the company from its current shareholders led by Warburg Pincus.
The new shareholders will continue to back the current management team, led by co-founders Joseph Priel (CEO) and Janos Mészáros (Chairman). Detailed terms of the transaction were not disclosed.
Euromedic is a fast-growing, pan-European medical services provider specialising in dialysis services and diagnostic imaging. The company recently entered the laboratory diagnostics and radiotherapy markets.
Euromedic’s services are provided across a network of 153 wholly-owned healthcare centres in 14 countries, in which the company contracts primarily with public insurance funds and hospitals.
Euromedic has benefited from increased levels of outsourcing by governments, both as the result of the restructuring of existing healthcare service provision and the move to address unmet service requirements.
With the backing of its new shareholders, Euromedic aims to further pursue its aggressive expansion strategy and strengthen its leading position in the growing and resilient dialysis and diagnostic imaging service markets across Eastern and Western Europe.
The company is broadening its reach and extending its services into laboratory diagnostics and radiotherapy within existing geographies and selectively expanding its geographic footprint.